*Dear Editor:*

**Re: Latex Content in Adult Vaccines, J. Davenport et al., December 10, 2019**

**Toxic, Allergenic MBT in Adult Vaccines**

This letter concerns the risks to health care workers---and to all the U.S. military---relating to administering vaccines from unit-dose syringes or from ampoules with natural rubber seals. Davenport et al. focus on the risk of latex allergy. They share the almost universal opinion that latex is the major source of allergic reactions---some of which are severe and occasionally fatal. Mercaptobenzothiazole (MBT), a rubber manufacturing catalyst, is the major hazard that is well known in the tire manufacturing industry. Those in the U.S. military who put their lives at risk in the line of duty should not be endangered unnecessarily from natural rubber contact with vaccines when safe synthetic rubber alternatives have been available for over 30 years. This risk is not confined to vaccines, but involves any injectable drug in contact with natural rubber in the packaging.

As the radiologist in a medical building shared with two urology professors, I injected 1,000 patients per year with contrast agents ("x-ray dyes") to outline the kidneys, ureters, and bladder on radiographs (IVP examinations). Such injections have a long history of producing reactions, some of which are fatal. Originally, I used plastic syringes with natural rubber plunger tips. In all cases, there was latex exposure. However, in two periods of time (1983 and 1987), I encountered discrete clusters of reactions with multiple hives, with one case of life-threatening anaphylaxis in each cluster. On each of these occasions, I discovered contamination of the injections with MBT (a vulcanization catalyst required to create rubber from latex) that was proven to leach from the natural rubber seals. In 1987, after eliminating syringe MBT by using imported Japanese syringes with no natural rubber, I encountered the second series of reactions related to MBT contamination from the ampoule seals made from natural rubber. This is discussed in the *Lancet* (Medical rubber anaphylaxis, 1990).

MBT is also toxic. Because it bounds to plasma proteins, it cannot be excreted by the kidneys, making it a cumulative toxin that increases in concentration with each contaminated injection; this makes children and hospitalized patients, including injured soldiers, who receive multiple injections, at particular risk. The plasma protein binding explains why MBT becomes a true IgE-mediated allergen because, when MBT combines with plasma proteins, the body can recognize it as a "foreign protein," similar to shellfish protein allergenicity. This is what triggered the anaphylactic reactions I encountered following IVP injections for renal investigation. Because X-ray dyes are not proteins and do not bind to plasma proteins, they should not trigger anaphylaxis, which is why allergists, who were unaware of MBT, created a new category of severe reactions, termed "anaphylactoid."

Terumo, a major Japanese syringe manufacturer, revealed in the *Australia New Zealand Medical Journal* (1981) that their syringes caused death of human cells in cultures. Realizing the toxic implications in patients, Japan immediately began working on nontoxic rubber, finally mandating a nationwide conversion of all syringe and drug ampoule seals to a new safe synthetic rubber that became in effect by 1985. This included vaccines. However, Japanese health protection authorities dropped their guard in 2009, allowing the importation of Sanofi Pasteur whooping cough vaccine that was in contact with natural rubber. This resulted in four childhood immunization deaths in 2011 before the vaccine was taken off the market.

There is another facet to this. A large Japanese series (Katayama 1985) of X-ray dye injections to outline the urinary excretory system (IVPs), using a new expensive X-ray dye ("non-ionic"), showed a marked reduction in serious reactions compared to the older, much less expensive dyes ("ionic"), resulting in a worldwide shift to the use of the expensive nonionic dyes, with considerable unnecessary expense to health care worldwide. However, there was a major statistical flaw in the Japanese series: the syringes used for injecting---and all the ampoule seals in Japan---did not use natural rubber manufactured with MBT. The rest of the world injected dyes in contact with natural rubber---in disposable syringes and in the much less expensive X-ray ionic dye ampoules. A world expert on X-ray dyes, Elliot Lasser (*Radiology* 1997), revealed, using U.S. national (Food and Drug Administration \[FDA\]) statistics, that after 1990, the incidence of severe reactions using either the newer expensive dye or the cheaper dyes were similar (although there was one more death in those using the expensive variety).

In August 1998, the U.S. Health and Human Services issued a toothless "Final Rule" warning about clear labeling of medical devices (including prefilled unit-dose vaccines) because of the danger of natural rubber contact. However, as the Davenport et al. article proves, the hazard of MBT remains a threat to the U.S. military, and to the entire U.S. population.

Because your readers and U.S. military forces rely on vaccines to protect their health around the world, I felt compelled to alert you to this largely unrecognized hazard that has been allowed to persist in spite of over 30 years of available evidence. One can refer to the FDA's list---"Latex in vaccine packaging" to realize to what degree your people have been exposed to MBT in vaccines in the past---and continue to be in the present, because of the failure of U.S. health protection agencies to protect your military---and the population in general. This is discussed by the World Health Organization's Drug Monitoring Centre, Sweden, in the April 2013 issue of the Uppsala Reports, which features a review of my 2011 "important book"---"The Nurses are Innocent -- The Digoxin Poisoning Fallacy," which also reveals MBT was falsely read as digoxin, leading to false murder charges.

Davenport et al. should examine different vaccine lots for MBT content, but not obtaining them from the manufacturer to ensure that the test samples are random. Such contamination would involve many other drugs in ampoules and in unit-dose delivery packaging with rubber seals (e.g., military dentist's local anesthetics).
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